This is a well established, profitable company with premium products. It has been sold down over the last 6 months due to lower sales in the first half. Not surprising capital sales can be lumpy, especially with possible impacts on the US healthcare system from Trump.
We are now getting back to a reasonable share price, but I still see plenty of potential business growth over the next few years, leading to much higher share prices.
CMP Price at posting:
70.0¢ Sentiment: Buy Disclosure: Held
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)